Innovative Discoveries Series

Elucidating modifiable risk factors for adverse prostate cancer outcomes and strategies for improving survival

Although prostate cancer has a high overall survival rate, it remains a disease of disparities with few established risk factors beyond age, family history, and race. However, there is growing focus on modifiable risk factors. This talk will examine modifiable risk factors for adverse prostate cancer outcomes throughout the cancer continuum. Specifically, research examining the association between weight gain, obesity, smoking, and diabetes and adverse prostate cancer outcomes including prostate cancer aggressiveness, progression, and mortality will be discussed. Finally, ongoing research, utilizing national VA data, examining the chemotherapeutic potential of metformin and satins to improve survival outcomes in men with prostate cancer will be highlighted.

Presented By:

Saira Khan, PhD, MPH

Assistant Professor, Epidemiology, College of Health Sciences, University of Delaware

Free!  Lunch will be served!

This activity has been approved for AMA PRA Category 1 Credit.

REGISTER ONLINE TODAY!

Friday, January 24, 2020
Noon to 1 p.m.
In-person: Christiana Hospital, Ammon Center, Room 14
Online: Watch live at https://bluejeans.com/361095905
Or join meeting ID 361095905 on the BlueJeans app on your smartphone or tablet

This activity has been approved for AMA PRA Category 1 Credit.

Upcoming Lectures:

January 30, 2020: From Public Health to Population Health